ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40909112

Quercetin boosts gut microbiota-driven production of isovanillic acid to alleviate colitis via enhancing intestinal barrier function.

Lei L and 9 others. Curr Res Food Sci, 2025. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Quercetin boosts gut microbiota-driven production of isovanillic acid to alleviate colitis via enhancing intestinal barrier function. Papers, record 40909112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40909112

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quercetin boosts gut microbiota-driven production of isovanillic acid to alleviate colitis via enhancing intestinal barrier function.
PubMed
Journal
Curr Res Food Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
4.15, provisional
iCite
Revised in PubMed
2025-09-15
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lei LLiang
2Wang JJing
3Wang JJuanjuan
4He WWenjuan
5Wu TTao
6Li JJing
7Bi XXiaobin
8Mei MMei
9Guan XXinlei
10Zhu XXiaoqiang

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,181,047Dietary Porphyra tenera ameliorated dextran sodium sulfate-induced colitis in mice via modulating gut microbiota dysbiosis.Food Chem2024https://conductscience.org/library/papers/39181047PubMed
237,526,178Isovanillic acid protects mice against Staphylococcus aureus by targeting vWbp and Coa.Future Microbiol2023https://conductscience.org/library/papers/37526178PubMed
336,587,451Quercetin alleviates intestinal inflammation and improves intestinal functions via modulating gut microbiota composition in LPS-challenged laying hens.Poult Sci2023https://conductscience.org/library/papers/36587451PubMed
435,021,901Current advances in the anti-inflammatory effects and mechanisms of natural polysaccharides.Crit Rev Food Sci Nutr2023https://conductscience.org/library/papers/35021901PubMed
535,935,939Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.Front Immunol2022https://conductscience.org/library/papers/35935939PubMed
640,027,479Gut microbiota in treating inflammatory digestive diseases: Current challenges and therapeutic opportunities.Imeta2025https://conductscience.org/library/papers/40027479PubMed
734,977,384Dietary ferulic acid and vanillic acid on inflammation, gut barrier function and growth performance in lipopolysaccharide-challenged piglets.Anim Nutr2022https://conductscience.org/library/papers/34977384PubMed
820,959,795The beneficial effect of vanillic acid on ulcerative colitis.Molecules2010https://conductscience.org/library/papers/20959795PubMed
928,743,984Gut microbiota and IBD: causation or correlation?Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/28743984PubMed
1035,087,228Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity.Nat Microbiol2022https://conductscience.org/library/papers/35087228PubMed

1 to 10 of 51

See all 51 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42,939,916Deciphering the Redox-Mediated Interplay Along the Gut-Lung-Brain Axis: Macrophage and Microglia Hyperactivation in Systemic Inflammation.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939916PubMed
42,889,568Pharmacological mechanisms of quercetin in liver and intestinal diseases: a gut-liver axis perspective.Front Pharmacol2026https://conductscience.org/library/papers/42889568PubMed
42,609,458Research Advances on the Molecular Structural Basis and Mechanisms of Quercetin and Its Derivatives in Improving Insulin Resistance.Drug Des Devel Ther2026https://conductscience.org/library/papers/42609458PubMed
42,486,818[Isovanillic acid alleviates dextran sulfate sodium-induced ulcerative colitis in mice by improving mitochondrial function via activating the PPARγ pathway].Nan Fang Yi Ke Da Xue Xue Bao2026https://conductscience.org/library/papers/42486818PubMed
42,404,004Targeting the Gut Microbiota with Herbal Compounds from Traditional Chinese Medicine: A Mechanistic Synthesis of a Novel Therapeutic Approach for Ulcerative Colitis.J Inflamm Res2026https://conductscience.org/library/papers/42404004PubMed
42,289,709Food-grade TiO2 impairs intestinal mucus barrier via disrupting the gut microbiota-ILA-mucin sulfation axis: novel insights and dietary intervention strategies.J Nanobiotechnology2026https://conductscience.org/library/papers/42289709PubMed
42,280,421Ginseng Bioactive Components as Gut-Brain Axis-Targeted Modulators: Therapeutic Potential and Mechanisms in Multifactorial Diseases.Nutrients2026https://conductscience.org/library/papers/42280421PubMed
42,280,375Inonotus obliquus Crude Melanin Ameliorates DSS-Induced Colitis with Modulation of Gut Microbiota and Neutrophil pro-NETotic Activation.Nutrients2026https://conductscience.org/library/papers/42280375PubMed
42,280,144Natural Bioactive Compounds Targeting Gut Barrier Integrity and Metabolic Endotoxemia in Cardiometabolic Disease: Mechanistic Insights and Translational Perspectives.Molecules2026https://conductscience.org/library/papers/42280144PubMed
42,243,877Unveiling medication patterns in traditional Chinese medicine for the prevention of colorectal cancer recurrence: from potential combinations to validation of components and targets.Chin Med2026https://conductscience.org/library/papers/42243877PubMed

1 to 10 of 12

See all 12 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40909112

GET https://conductscience.org/api/papers/v1/40909112/references?page=2

API referenceFor AI assistants